位置:首页 > 蛋白库 > GNPI1_HUMAN
GNPI1_HUMAN
ID   GNPI1_HUMAN             Reviewed;         289 AA.
AC   P46926; B7Z3X4; D3DQE7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   03-AUG-2022, entry version 194.
DE   RecName: Full=Glucosamine-6-phosphate isomerase 1;
DE            EC=3.5.99.6 {ECO:0000269|PubMed:21807125};
DE   AltName: Full=Glucosamine-6-phosphate deaminase 1;
DE            Short=GNPDA 1;
DE            Short=GlcN6P deaminase 1;
DE   AltName: Full=Oscillin;
GN   Name=GNPDA1 {ECO:0000303|PubMed:26887390, ECO:0000312|HGNC:HGNC:4417};
GN   Synonyms=GNPI, HLN, KIAA0060;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9438414; DOI=10.1096/fasebj.12.1.91;
RA   Wolosker H., Kline D., Bian Y., Blackshaw S., Cameron A.M., Fralich T.J.,
RA   Schnaar R.L., Snyder S.H.;
RT   "Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes
RT   to transporting epithelium and lacks oscillin activity.";
RL   FASEB J. 12:91-99(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=9714720; DOI=10.1016/s0378-1119(98)00335-7;
RA   Shevchenko V., Hogben M., Ekong R., Parrington J., Lai F.A.;
RT   "The human glucosamine-6-phosphate deaminase gene: cDNA cloning and
RT   expression, genomic organization and chromosomal localization.";
RL   Gene 216:31-38(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Hirata S., Koh T., Hoshi K.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N.,
RA   Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II. The
RT   coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-64, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF 268-PRO--ASP-289 AND 275-LYS--ASP-289.
RX   PubMed=21807125; DOI=10.1016/j.bbapap.2011.07.010;
RA   Alvarez-Anorve L.I., Alonzo D.A., Mora-Lugo R., Lara-Gonzalez S.,
RA   Bustos-Jaimes I., Plumbridge J., Calcagno M.L.;
RT   "Allosteric kinetics of the isoform 1 of human glucosamine-6-phosphate
RT   deaminase.";
RL   Biochim. Biophys. Acta 1814:1846-1853(2011).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=26887390; DOI=10.1093/glycob/cww019;
RA   Oikari S., Makkonen K., Deen A.J., Tyni I., Kaernae R., Tammi R.H.,
RA   Tammi M.I.;
RT   "Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes
RT   in the maintenance of UDP-GlcNAc content and hyaluronan synthesis.";
RL   Glycobiology 26:710-722(2016).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS), AND SUBUNIT.
RX   PubMed=12965206; DOI=10.1016/s0014-5793(03)00896-2;
RA   Arreola R., Valderrama B., Morante M.L., Horjales E.;
RT   "Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic
RT   study.";
RL   FEBS Lett. 551:63-70(2003).
CC   -!- FUNCTION: Catalyzes the reversible conversion of alpha-D-glucosamine 6-
CC       phosphate (GlcN-6P) into beta-D-fructose 6-phosphate (Fru-6P) and
CC       ammonium ion, a regulatory reaction step in de novo uridine
CC       diphosphate-N-acetyl-alpha-D-glucosamine (UDP-GlcNAc) biosynthesis via
CC       hexosamine pathway. Deamination is coupled to aldo-keto isomerization
CC       mediating the metabolic flux from UDP-GlcNAc toward Fru-6P. At high
CC       ammonium level can drive amination and isomerization of Fru-6P toward
CC       hexosamines and UDP-GlcNAc synthesis (PubMed:21807125,
CC       PubMed:26887390). Has a role in fine tuning the metabolic fluctuations
CC       of cytosolic UDP-GlcNAc and their effects on hyaluronan synthesis that
CC       occur during tissue remodeling (PubMed:26887390). Seems to trigger
CC       calcium oscillations in mammalian eggs. These oscillations serve as the
CC       essential trigger for egg activation and early development of the
CC       embryo (By similarity). {ECO:0000250|UniProtKB:Q64422,
CC       ECO:0000269|PubMed:21807125, ECO:0000269|PubMed:26887390}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-D-glucosamine 6-phosphate + H2O = beta-D-fructose 6-
CC         phosphate + NH4(+); Xref=Rhea:RHEA:12172, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:57634, ChEBI:CHEBI:75989; EC=3.5.99.6;
CC         Evidence={ECO:0000269|PubMed:21807125};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12173;
CC         Evidence={ECO:0000305|PubMed:21807125, ECO:0000305|PubMed:26887390};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:12174;
CC         Evidence={ECO:0000305|PubMed:21807125, ECO:0000305|PubMed:26887390};
CC   -!- ACTIVITY REGULATION: Allosterically activated by N-acetylglucosamine-6-
CC       phosphate (GlcNAc6P). {ECO:0000269|PubMed:21807125}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16.5 mM for alpha-D-glucosamine 6-phosphate (in the presence of
CC         GlcNAc6P) {ECO:0000269|PubMed:21807125};
CC         KM=0.27 mM for alpha-D-glucosamine 6-phosphate (in the absence of
CC         GlcNAc6P) {ECO:0000269|PubMed:21807125};
CC         KM=6.6 mM for beta-D-fructose 6-phosphate (in the presence of
CC         GlcNAc6P) {ECO:0000269|PubMed:21807125};
CC         KM=6.6 mM for NH4(+) (in the presence of GlcNAc6P)
CC         {ECO:0000269|PubMed:21807125};
CC         Note=kcat is 228 sec(-1) for conversion of alpha-D-glucosamine 6-
CC         phosphate into beta-D-fructose 6-phosphate (in the presence of
CC         GlcNAc6P). kcat is 0.14 sec(-1) for conversion of alpha-D-glucosamine
CC         6-phosphate into beta-D-fructose 6-phosphate (in the absence of
CC         GlcNAc6P). kcat is 0.84 sec(-1) for conversion of beta-D-fructose 6-
CC         phosphate into alpha-D-glucosamine 6-phosphate (in the presence of
CC         GlcNAc6P). {ECO:0000269|PubMed:21807125};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; alpha-D-glucosamine 6-phosphate from D-
CC       fructose 6-phosphate: step 1/1. {ECO:0000305|PubMed:26887390}.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:12965206}.
CC   -!- INTERACTION:
CC       P46926; P43364-2: MAGEA11; NbExp=3; IntAct=EBI-749356, EBI-10178634;
CC       P46926; Q9NRG1: PRTFDC1; NbExp=3; IntAct=EBI-749356, EBI-739759;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P46926-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46926-2; Sequence=VSP_057011;
CC   -!- SIMILARITY: Belongs to the glucosamine/galactosamine-6-phosphate
CC       isomerase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA06544.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF048826; AAC05123.1; -; mRNA.
DR   EMBL; AJ002231; CAA05259.1; -; mRNA.
DR   EMBL; AF029914; AAB84217.1; -; mRNA.
DR   EMBL; AF035809; AAB88748.1; -; Genomic_DNA.
DR   EMBL; AF035804; AAB88748.1; JOINED; Genomic_DNA.
DR   EMBL; AF035805; AAB88748.1; JOINED; Genomic_DNA.
DR   EMBL; AF035806; AAB88748.1; JOINED; Genomic_DNA.
DR   EMBL; AF035807; AAB88748.1; JOINED; Genomic_DNA.
DR   EMBL; AF035808; AAB88748.1; JOINED; Genomic_DNA.
DR   EMBL; D31766; BAA06544.2; ALT_INIT; mRNA.
DR   EMBL; AK296452; BAH12360.1; -; mRNA.
DR   EMBL; AC005740; AAC62119.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61890.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61891.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61892.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61893.1; -; Genomic_DNA.
DR   EMBL; BC012853; AAH12853.1; -; mRNA.
DR   EMBL; BC020769; AAH20769.1; -; mRNA.
DR   EMBL; BC022322; AAH22322.1; -; mRNA.
DR   CCDS; CCDS4272.1; -. [P46926-1]
DR   RefSeq; NP_005462.1; NM_005471.4. [P46926-1]
DR   RefSeq; XP_006714810.1; XM_006714747.2. [P46926-1]
DR   RefSeq; XP_011535839.1; XM_011537537.1. [P46926-1]
DR   PDB; 1NE7; X-ray; 1.75 A; A/B/C/D/E/F=1-289.
DR   PDBsum; 1NE7; -.
DR   AlphaFoldDB; P46926; -.
DR   SMR; P46926; -.
DR   BioGRID; 115325; 50.
DR   IntAct; P46926; 11.
DR   MINT; P46926; -.
DR   STRING; 9606.ENSP00000423674; -.
DR   DrugBank; DB02445; 2-Deoxy-2-Amino Glucitol-6-Phosphate.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   DrugBank; DB03951; N-acetyl-D-glucosamine-6-phosphate.
DR   GlyGen; P46926; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P46926; -.
DR   MetOSite; P46926; -.
DR   PhosphoSitePlus; P46926; -.
DR   BioMuta; GNPDA1; -.
DR   EPD; P46926; -.
DR   jPOST; P46926; -.
DR   MassIVE; P46926; -.
DR   MaxQB; P46926; -.
DR   PaxDb; P46926; -.
DR   PeptideAtlas; P46926; -.
DR   PRIDE; P46926; -.
DR   ProteomicsDB; 55767; -. [P46926-1]
DR   ProteomicsDB; 6552; -.
DR   Antibodypedia; 606; 255 antibodies from 32 providers.
DR   DNASU; 10007; -.
DR   Ensembl; ENST00000311337.11; ENSP00000311876.6; ENSG00000113552.16. [P46926-1]
DR   Ensembl; ENST00000500692.6; ENSP00000424275.1; ENSG00000113552.16. [P46926-1]
DR   Ensembl; ENST00000503794.5; ENSP00000423485.1; ENSG00000113552.16. [P46926-1]
DR   Ensembl; ENST00000508177.5; ENSP00000423674.1; ENSG00000113552.16. [P46926-1]
DR   GeneID; 10007; -.
DR   KEGG; hsa:10007; -.
DR   MANE-Select; ENST00000311337.11; ENSP00000311876.6; NM_005471.5; NP_005462.1.
DR   UCSC; uc003lmf.5; human. [P46926-1]
DR   CTD; 10007; -.
DR   DisGeNET; 10007; -.
DR   GeneCards; GNPDA1; -.
DR   HGNC; HGNC:4417; GNPDA1.
DR   HPA; ENSG00000113552; Low tissue specificity.
DR   MIM; 601798; gene.
DR   neXtProt; NX_P46926; -.
DR   OpenTargets; ENSG00000113552; -.
DR   PharmGKB; PA28796; -.
DR   VEuPathDB; HostDB:ENSG00000113552; -.
DR   eggNOG; KOG3148; Eukaryota.
DR   GeneTree; ENSGT00390000014316; -.
DR   InParanoid; P46926; -.
DR   OMA; FNEPCSS; -.
DR   OrthoDB; 1425290at2759; -.
DR   PhylomeDB; P46926; -.
DR   TreeFam; TF300841; -.
DR   BRENDA; 3.5.99.6; 2681.
DR   PathwayCommons; P46926; -.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   SABIO-RK; P46926; -.
DR   SignaLink; P46926; -.
DR   UniPathway; UPA00113; UER00528.
DR   BioGRID-ORCS; 10007; 8 hits in 1083 CRISPR screens.
DR   ChiTaRS; GNPDA1; human.
DR   EvolutionaryTrace; P46926; -.
DR   GeneWiki; GNPDA1; -.
DR   GenomeRNAi; 10007; -.
DR   Pharos; P46926; Tbio.
DR   PRO; PR:P46926; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P46926; protein.
DR   Bgee; ENSG00000113552; Expressed in type B pancreatic cell and 211 other tissues.
DR   ExpressionAtlas; P46926; baseline and differential.
DR   Genevisible; P46926; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0004342; F:glucosamine-6-phosphate deaminase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB.
DR   GO; GO:0006043; P:glucosamine catabolic process; IMP:UniProtKB.
DR   GO; GO:0006046; P:N-acetylglucosamine catabolic process; IBA:GO_Central.
DR   GO; GO:0019262; P:N-acetylneuraminate catabolic process; IBA:GO_Central.
DR   GO; GO:0007338; P:single fertilization; TAS:ProtInc.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IMP:UniProtKB.
DR   CDD; cd01399; GlcN6P_deaminase; 1.
DR   HAMAP; MF_01241; GlcN6P_deamin; 1.
DR   InterPro; IPR006148; Glc/Gal-6P_isomerase.
DR   InterPro; IPR004547; Glucosamine6P_isomerase.
DR   InterPro; IPR018321; Glucosamine6P_isomerase_CS.
DR   InterPro; IPR037171; NagB/RpiA_transferase-like.
DR   PANTHER; PTHR11280; PTHR11280; 1.
DR   Pfam; PF01182; Glucosamine_iso; 1.
DR   SUPFAM; SSF100950; SSF100950; 1.
DR   TIGRFAMs; TIGR00502; nagB; 1.
DR   PROSITE; PS01161; GLC_GALNAC_ISOMERASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Carbohydrate metabolism;
KW   Cytoplasm; Hydrolase; Isomerase; Phosphoprotein; Reference proteome.
FT   CHAIN           1..289
FT                   /note="Glucosamine-6-phosphate isomerase 1"
FT                   /id="PRO_0000160122"
FT   ACT_SITE        72
FT                   /note="Proton acceptor; for enolization step"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        141
FT                   /note="For ring-opening step"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        143
FT                   /note="Proton acceptor; for ring-opening step"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        148
FT                   /note="For ring-opening step"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         64
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         161
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O88958"
FT   VAR_SEQ         69..145
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057011"
FT   MUTAGEN         268..289
FT                   /note="Missing: Decreases hexamer stability and catalytic
FT                   efficiency."
FT                   /evidence="ECO:0000269|PubMed:21807125"
FT   MUTAGEN         275..289
FT                   /note="Missing: Decreases catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:21807125"
FT   STRAND          2..8
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           9..27
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          35..39
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           43..57
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          66..74
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           85..92
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           94..96
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           101..103
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           114..127
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           164..170
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   TURN            174..176
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          183..187
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           190..194
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           206..208
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           209..216
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           225..231
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   STRAND          233..240
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           241..244
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           249..257
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           259..262
FT                   /evidence="ECO:0007829|PDB:1NE7"
FT   HELIX           263..265
FT                   /evidence="ECO:0007829|PDB:1NE7"
SQ   SEQUENCE   289 AA;  32669 MW;  4111F655D574F74F CRC64;
     MKLIILEHYS QASEWAAKYI RNRIIQFNPG PEKYFTLGLP TGSTPLGCYK KLIEYYKNGD
     LSFKYVKTFN MDEYVGLPRD HPESYHSFMW NNFFKHIDIH PENTHILDGN AVDLQAECDA
     FEEKIKAAGG IELFVGGIGP DGHIAFNEPG SSLVSRTRVK TLAMDTILAN ARFFDGELTK
     VPTMALTVGV GTVMDAREVM ILITGAHKAF ALYKAIEEGV NHMWTVSAFQ QHPRTVFVCD
     EDATLELKVK TVKYFKGLML VHNKLVDPLY SIKEKETEKS QSSKKPYSD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024